Literature DB >> 16211122

Dyslipidaemia among black patients with type 2 diabetes.

Z B Vezi1, D P Naidoo.   

Abstract

OBJECTIVE: To analyse the lipid profile of black patients with type 2 diabetes mellitus (type 2 DM) irrespective of duration or control of the disease.
METHODS: This cross-sectional study evaluated the lipid profile of 62 black patients with type 2 DM. Clinical examination, fasting blood specimens for biochemistry, and urine analysis for proteinuria was determined in all patients.
RESULTS: Only 25% of patients had adequately controlled blood pressure (BP < 140/90). Mean fasting plasma glucose (FPG) was 10.9 mmol/l (HbA1c: 10.6%). Mean body mass index (BMI) was 32.5. The total number of patients with diabetic dyslipidaemia (DD) was 56 (90.3%). Significant differences between men and women were noted for high-density lipoprotein cholesterol (HDL-C) (0.99 vs 1.22 mmol/l, p = 0.005) and triglycerides (TG) (2.7 vs 1.8 mmol/l, p = 0.045), respectively. The commonest isolated abnormality was high LDL-C (66.1%) followed by low HDL-C (60.7%) and then high TG (57.1%).
CONCLUSION: Over 90% of the black patients with type 2 DM displayed one or more features of DD affecting all major subclasses of cholesterol and triglyceride. The most frequent abnormality depicted by these patients was not the 'typical' DD (i.e. low HDL and high TG) often reported in other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211122

Source DB:  PubMed          Journal:  Cardiovasc J S Afr


  2 in total

1.  Prevalence of Dyslipidaemia among Type 2 Diabetes Mellitus Patients in the Western Cape, South Africa.

Authors:  Elizabeth I Omodanisi; Yibanathi Tomose; Benjamin I Okeleye; Seteno K O Ntwampe; Yapo G Aboua
Journal:  Int J Environ Res Public Health       Date:  2020-11-24       Impact factor: 3.390

2.  Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.

Authors:  Charity Masilela; Oladele Vincent Adeniyi; Mongi Benjeddou
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.